Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products to address anti-D immunoglobulin supply chain vulnerabilities

Human medicines European public assessment report (EPAR): Neoatricon, dopamine hydrochloride, Date of authorisation: 27/05/2024, Revision: 1, Status: Authorised

Agenda of the HMPC meeting 7-9 July 2025

First EMA-ACRO bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 2 September 2025

Combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products - Rev.16

EudraVigilance Veterinary

Human medicines European public assessment report (EPAR): Cufence, trientine dihydrochloride, Date of authorisation: 25/07/2019, Revision: 8, Status: Authorised

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 May 2025, 15:00 (CEST) to 19 May 2025, 16:00 (CEST)

Network Data Steering Group workplan 2025-2028

Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 8, Status: Authorised